Fundamentals

Valuation

Metric	Q1	Q3	Δ in %
EV/EBITDA	-53.53	42.78	92.05
Graham Fair Price	-23.82	1.15	1.52
PEG	177.07	-4.14	1.50
Price/Book	-8.48	0.65	0.71
Price/Cash Flow	-58.26	14.95	-35.82
Prices/Earnings	54.58	204.13	-132.05
Price/Sales	-19.47	3.12	3.88
Price/FCF	-58.26	14.95	-35.82
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q3	Δ in %
Gross Profit Margin	10.11	0.16	0.15
Operating Margin	584.05	0.02	< 0.005
ROA	-41.08	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-40.80
ROIC	< 0.005	< 0.005	1.17
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q3	Δ in %
Debt QOQ	-0.09	-0.06	-47.71
Dividends QOQ	-0.95	-0.90	5.34
EBIT QOQ	0.94	6.27	564.68
EPS QOQ	0.88	-0.49	-44.21
FCF QOQ	-2.43	3.69	51.98
Revenue QOQ	-0.42	0.10	-74.81
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	48.75	37.84	-22.38
Days Sales Outstanding (DSO)	163.40	129.69	-20.63
Inventory Turnover	1.85	2.38	28.83
Debt/Capitalization	0.27	0.26	-4.52
Quick Ratio	1.82	1.93	6.47
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q3	Δ in %
Book Value	8.73	12.94	48.23
Cash	4.79	5.13	7.02
Capex	-0.12	0.04	-67.85
Free Cash Flow	-0.17	0.37	117.10
Revenue	1.59	1.79	12.52
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q1	Q3	Δ in %
Current Ratio	2.06	2.08	1.21
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-31.92	-26.79	16.06
Naive Interpretation	Member

06 - Financial Health · Bad

Rating